{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-14",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20050830",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "42321",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021839_IncrelexTOC.html",
              "date": "20200323",
              "type": "Review"
            },
            {
              "id": "6278",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021839ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "16435",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021839lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20110216",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "16436",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021839s007ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "28681",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021839s007lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "27",
          "submission_status": "AP",
          "submission_status_date": "20231020",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "75893",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/021839Orig1s027ltr.pdf",
              "date": "20231024",
              "type": "Letter"
            },
            {
              "id": "75912",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021839s027lbl.pdf",
              "date": "20231024",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "33",
          "submission_status": "AP",
          "submission_status_date": "20250709",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "82776",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/021839Orig1s033ltr.pdf",
              "date": "20250711",
              "type": "Letter"
            },
            {
              "id": "82807",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021839s033lbl.pdf",
              "date": "20250711",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "17",
          "submission_status": "AP",
          "submission_status_date": "20160315",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "6279",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021839s017lbl.pdf",
              "date": "20200323",
              "type": "Label"
            },
            {
              "id": "16437",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021839Orig1s017ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "31",
          "submission_status": "AP",
          "submission_status_date": "20240315",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "77856",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021839Orig1s031ltr.pdf",
              "date": "20240318",
              "type": "Letter"
            },
            {
              "id": "77911",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021839s031lbl.pdf",
              "date": "20240321",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "21",
          "submission_status": "AP",
          "submission_status_date": "20190118",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "57286",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021839Orig1s021ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "57299",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021839s021lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "24",
          "submission_status": "AP",
          "submission_status_date": "20191203",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "61142",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021839Orig1s024ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "61168",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021839s024lbl.pdf",
              "date": "20200323",
              "type": "Label"
            },
            {
              "id": "67759",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=faq.page#nda_bla",
              "date": "20210610",
              "type": "Other"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "16",
          "submission_status": "AP",
          "submission_status_date": "20140603",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "28684",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021839s016lbl.pdf",
              "date": "20200323",
              "type": "Label"
            },
            {
              "id": "37739",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021839Orig1s016ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "14",
          "submission_status": "AP",
          "submission_status_date": "20130116",
          "review_priority": "PRIORITY",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "12",
          "submission_status": "AP",
          "submission_status_date": "20120614",
          "review_priority": "UNKNOWN",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "37738",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021839s012ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            },
            {
              "id": "28683",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021839s012lbl.pdf",
              "date": "20200323",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20120913",
          "review_priority": "UNKNOWN",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "37737",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021839s010lbl.pdf",
              "date": "20200323",
              "type": "Label"
            },
            {
              "id": "28682",
              "title": "This Former NDA Was Deemed To Be a BLA on March 23, 2020.",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021839Origs010ltr.pdf",
              "date": "20200323",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "BLA021839",
      "sponsor_name": "IPSEN INC",
      "openfda": {
        "application_number": [
          "BLA021839"
        ],
        "brand_name": [
          "INCRELEX"
        ],
        "generic_name": [
          "MECASERMIN"
        ],
        "manufacturer_name": [
          "Ipsen Biopharmaceuticals, Inc.",
          "Eton Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "15054-1040",
          "71863-216"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "MECASERMIN"
        ],
        "rxcui": [
          "604806",
          "615882"
        ],
        "spl_id": [
          "21eb91ba-3cd8-47f0-a27b-35e3e5fd2e10",
          "52199e09-74a6-6144-e063-6294a90a59e7"
        ],
        "spl_set_id": [
          "a8b27a1b-a611-4f91-ad22-76d4b390c3ae",
          "d5b2b0e1-c523-468d-9a0b-4ae4e4a8dbce"
        ],
        "package_ndc": [
          "15054-1040-5",
          "71863-216-04"
        ],
        "unii": [
          "7GR9I2683O"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "INCRELEX",
          "active_ingredients": [
            {
              "name": "MECASERMIN RECOMBINANT",
              "strength": "40MG/4ML (10MG/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}